{"schema_version":"secwatch.filing_event.v1","accession":"0000711404-23-000029","form_type":"8-K","ticker":"COO","cik":"0000711404","company_name":"COOPER COMPANIES, INC.","filed_at":"2023-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.981929+00:00","generated_at":"2026-06-14T09:56:59.057960+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cooper Q2 revenue up 6% to $877M; GAAP EPS slumps 69% to $0.80; FY23 guidance updated","bullets":["Revenue $877.4M, up 6% YoY (9% constant currency, 8% organic); GAAP diluted EPS $0.80 vs $2.55 last year.","Non-GAAP diluted EPS $3.08, down $0.16 or 5% YoY; gross margin 66% on GAAP, 67% non-GAAP.","CooperVision organic growth 10% (9th consecutive double-digit quarter); CooperSurgical fertility up 11% organic.","FY23 guidance: revenue $3,512-$3,569M (organic 7-9%), non-GAAP EPS $12.66-$12.96.","Free cash flow $50.6M; net debt $2.5B down $48.5M from prior quarter; interest expense $26.1M."],"urls":{"canonical":"https://secwatch.observer/filing/0000711404-23-000029","json":"https://secwatch.observer/filing/0000711404-23-000029.json","markdown":"https://secwatch.observer/filing/0000711404-23-000029.md","text":"https://secwatch.observer/filing/0000711404-23-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711404/000071140423000029/0000711404-23-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711404/000071140423000029/coo-20230601.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T09:56:59.057960+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ec13ca1410d7ce2ae5a7cae2360012c4970f4e16","claim":"COOPER COMPANIES, INC. reported its fiscal second quarter ended April 30, 2023 results: revenue $877.4 million, EPS GAAP diluted earnings per share (EPS) of $0.80. Guidance reaffirmed.","evidence_excerpt":"PRESS RELEASE CooperCompanies Announces Second Quarter 2023 Results San Ramon, Calif., June 1, 2023 — CooperCompanies (NYSE: COO) today announced financial results for its fiscal second quarter ended April 30, 2023. • Revenue increased 6% year-over-year to $877.4 million. CooperVision (CVI) revenue up 6% to $589.3 million, and CooperSurgical (CSI) revenue up 4% to $288.1 million. • GAAP diluted earnings per share (EPS) of $0.80, down $1.75 or 69% from last year's second quarter. • Non-GAAP diluted EPS of $3.08, down $ 0.16 o r 5% from last year's second quarter.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/711404/000071140423000029/0000711404-23-000029-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"its fiscal second quarter ended April 30, 2023"},{"label":"Revenue","value":"$877.4 million"},{"label":"EPS","value":"GAAP diluted earnings per share (EPS) of $0.80"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}